WednesdayOct 12, 2022 11:52 am

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Publication of Innovative Mathematical Model

Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology. The publication, titled “A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination,” describes a model developed with Dr. Lisette de Pillis, a professor of life sciences and mathematics at Harvey Mudd College. NAb inhibit viral binding to the human cell receptor thereby reducing…

Continue Reading

TuesdayOct 11, 2022 1:25 pm

QualityStocksNewsBreaks – SPYR Technologies (SPYR) Readies for Market Launch of World’s Smallest, Low-Cost Tracking Modems

SPYR (OTCQB: SPYR), a diversified technology company developing products leveraging the internet of things (“IoT”) for consumer use and large-scale applications and industries, today outlined recently reported disclosures in its June 30 10-Q and commented on corporate developments. According to the update, the company, via its GeoTraq subsidiary, is at the forefront of the technology development of novel tracking modems. “With our SEC filings up to date, the GeoTraq acquisition fully integrated, and our recently completed manufacturing contract with Asiatelco Technologies Co. in place, we are now laser-focused on readying our market launch of the world’s smallest, low-power, low-cost tracking…

Continue Reading

TuesdayOct 11, 2022 1:19 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Seasoned Veteran as New Chief Medical Officer

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, has named a new chief medical officer. Renowned Stanford cardiologist Peter J. Fitzgerald, MD, PhD, will be joining the HeartBeam executive team and will support the planned advancement of the company’s product pipeline. Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School, Fitzgerald is an interventional cardiologist and has led or participated in more than 175 clinical trials and has published some 650 manuscripts/chapters. He has…

Continue Reading

TuesdayOct 11, 2022 12:52 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Announces Formation of Subsidiary Focused on Treating Neurological Disorders

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today announced the formation of Odyssey Neuropharma Inc. According to the update, the wholly owned subsidiary will focus on developing drugs to treat neurological disorders. The blood-brain barrier (“BBB”) represents a significant obstacle for drug delivery to the brain, and many drugs have failed in neuroscience research due to the inability to jump the hurdle that is the BBB. Odyssey will utilize its unique intranasal delivery device coupled with its powdered formulations to allow drugs to be delivered more directly to the brain, providing for quick and…

Continue Reading

TuesdayOct 11, 2022 12:24 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Names New Executive

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, has named a new chief of commercialization. The company has appointed James Bolen, an advisor to the company, to the position. Bolen has decades of experience developing and commercializing products designed for automotive and industrial power spaces. Bolen noted that HLRTF’s development program is focused on a high level of customer intimacy, which ensures consistent customer requirements and product specifications, followed by application-specific customization. The company has dedicated itself to assembling an experienced, capable leadership…

Continue Reading

TuesdayOct 11, 2022 11:22 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), joined partner The Chopra Foundation in recognizing World Mental Health Day, which was Monday, Oct. 11, 2022. The two organizations are working together to research the potential of psychedelic-based therapies for the treatment of mental health and to provide education about the use of psychedelics. Founded by Dr. Deepak Chopra, The Chopra Foundation is a not-for-profit organization dedicated to improving health and well-being. World Mental Health Day was designed to create an opportunity for those with mental health issues, along with advocates, governments, employers, employees and…

Continue Reading

MondayOct 10, 2022 1:54 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Remains Laser-Focused to Deliver to Growing RNG Demand

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, recently reported financial results for the three- and six-month periods ended June 30, 2022. “Second quarter updates and highlights include milestones such as expansion across Canada, where the company now boasts a presence in three of the country’s four largest jurisdictions for RNG. Remaining laser-focused on its commitment to cater to the ballooning demand for RNG, EverGen has continued to execute its rapid growth strategy in Q2 2022. As a result, the company acquired a 50% interest in a portfolio of…

Continue Reading

MondayOct 10, 2022 1:35 pm

QualityStocksNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam (NASDAQ: BEAT) is a cardiac technology company whose initial focus is on providing diagnostic data through its 3D-vector 12-lead electrocardiogram (“ECG”) platform – the first and only to be developed – for heart attack detection anytime, anywhere. Its development portfolio includes HeartBeam AIMI(TM), a software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately and speedily identify a heart attack in acute care settings. Also under development is HeartBeam AIMIGo(TM), the first and only credit card-sized 12-lead output ECG device for remote heart attack detection that combines a smartphone app and cloud-based diagnostic software…

Continue Reading

MondayOct 10, 2022 12:04 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Offers Year-Round Farming Option, Higher-Nutrient Crops

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, provides a new income opportunity for farmers. The company’s GrowPods, or unique controlled environment farms, offer the ideal environment for farmers to grow crops all year long; as an added advantage, the crops are high nutrient, clean and sustainable. According to the announcement, recent reports have highlighted the challenges that farmers face, including increasing debt, extreme weather conditions, consolidation, degrading and eroding soils, and increased pesticide and chemical use that impact the nutrient value of harvests. One study noted that farmers are among the…

Continue Reading

MondayOct 10, 2022 11:57 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet need in brain tumor treatment is immense and knows no geographic borders. As CEO of CNS, I have come to know many brain tumor patients personally and the optimism and strength with which they have…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered